暂无相关信息!
[1] 中华医学会内分泌学会. 原发性醛固酮增多症诊断治疗的专家共识(2020版)[J]. 中华内分泌代谢杂志, 2020, 36(9): 727-736.
[2] Bernini G, Galetta F, Franzoni F, et al. Arterial stiffness,intima- media thickness and carotid artery fibrosis in patients with primary aldosteronism [J]. Hypertens, 2008, 26(12):2399-2405.
[3] Monticone S, D’Ascenzo F, Moretti C, et al. Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta- analysis [J]. Lancet Diabetes Endocrinol, 2018, 6(1): 41-50.
[4] van der Heijden C, Smeets EMM, Aarntzen E, et al. A rterial wall inflammation and increased hematopoietic activity in patients with primary aldosteronism [J]. Clin Endocrinol Metab, 2020, 105(5):e1967-e2980.
[5] Rossi GP, Cesari M, Cuspidi C, et al. Long- term control of arterial hypertension and regression of left ventricular hypertrophy with treatment of primary aldosteronism [J]. Hypertension, 2013, 62(1): 62-69.
[6] Nishikawa T, Omura M, Satoh F, et al. Guidelines for the diagnosis and treatment of primary aldosteronism- The Japan Endocrine Society 2009 [J]. Endocr J, 2011, 58(9): 711-721.
[7] Funder JW, Carey RM, Mantero F, et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline [J]. J Clin Endocrinol Metab, 2016, 101(5): 1889-1916.
[8] Rossi GP, Rossitto G, Amar L, et al. Clinical outcomes of 1625 patients with primary aldosteronism subtyped with adrenal vein sampling [J]. Hypertension, 2019, 74(4): 800- 808.
[9] W illiam s TA, B u rrello J, Sechi LA, e t al. C om pu ted tom ography and adrenal venous sampling in the diagnosis of unilateral primary aldosteronism [J]. Hypertension. 2018, 72(3): 641-649.
[10] Okamoto K, Ohno Y, Sone M, et al. Should Adrenal Venous Sampling Be Performed in PA Patients Without Apparent Adrenal Tumors [J]. Front Endocrinol (Lausanne), 2021, 4(12): 1-8.
[11] Pa rksook WW , Y ozam p N, H undem e r GL, e t al. M o rphologically Normal- Appearing Adrenal Glands as a P revalent Source of Aldosterone P roduction in P rimary Aldosteronism [J]. Am J Hypertens, 2022, 35(6): 561-571.
[12] Shariq OA, Bancos I, Cronin PA, et al. Contralateral suppression of aldosterone at adrenal venous sam pling predicts hyperkalemia following adrenalectomy for primary aldosteronism [J]. Surgery, 2018, 163(1): 183-190.
[13] Kubo H, Tsurutani Y, Inoue K, et al. Characteristics of aldosterone- producing adenomas in patients without plasma renin activity suppression [J]. PLoS One, 2022, 17(4): e0267732.
[14] Yasuda S, Hikima Y, Kabeya Y, et al. Clinical characterization of patients with primary aldosteronism plus subclinical Cushing’s syndrome [J]. BMC Endocr Disord, 2020, 20(1): 9.
[15] M ulatero P, Burrello J, William s TA, et al. P rimary Aldosteronism in the Elderly [J]. J Clin Endocrinol Metab, 2020, 105(7): dgaa206.
[16] Priya A, Narayan RK, Ghosh SK. Prevalence and clinical relevance of the anatomical variations of suprarenal arteries: a review [J]. Anat Cell Biol, 2022, 55(1): 28-39.
[17] W ang Y, Yang Z, Chang X, et al. Right laparoscopic adrenalectomy vs. left laparoscopic adrenalectomy: a systematic review and m e ta- analysis [J ]. W ideochir Inne T ech M aloinwazyjne, 2022, 17(1): 9-19.
[18] Kira S, Sawada N, Nakagomi H, et al. Mayo Adhesive Probability Score Is Associated with the Operative Time in Laparoscopic Adrenalectomy [J]. Laparoendosc Adv Surg Tech A, 2022, 32(6): 595-599.
[19] Yuan Y, Feng H, Kang Z, et al. Mayo adhesive probability score is associated with perioperative outcomes in retroperitoneal laparoscopic adrenalectomy [J]. ANZ J Surg, 2022: Online ahead of print.
[20] Nagaya N, Shimizu F, Kanayama M, et al. Movement of target organs and anatomical landmarks caused by body position change during urological laparoscopic surgery [J]. Asian J Endosc Surg, 2020, 13(1): 65-70.
[21] Liu JH, Wei XD, Fu CC, et al. Long- Term Results of Laparoscopic Partial Versus Total Adrenalectomy for Aldosterone Producing Adenoma [J]. Urol J, 2020, 17(4): 4981.
[22] Flammia RS, Anceschi U, Tufano A, et al. Minimally Invasive Partial vs. Total Adrenalectomy for the Treatment of Unilateral Primary Aldosteronism: A Systematic Review and Meta-Analysis [J]. J Clin Med, 2022, 11(5): 1263.
[23] Sebastian M, Rudnicki J. Recommendation for laparoscopic ultrasound guided laparoscopic left lateral transabdominal adrenalectomy [J]. Gland Surg, 2020, 9(3): 689-694.
[24] Liu Y, Z hu B, Z hu L, e t al. Clinical ou tcom es of lapa roscopic- based renal denervation plus adrenalectomy vs adrenalectomy alone for treating resistant hypertension caused by unilateral aldosterone- producing adenoma [J]. Clin Hypertens, 2020, 22(9): 1606-1615.
[25] Liu Y, Zhu B, Zhu L, et al. Thirty- six-month results of lapa roscopic- based renal dene rva tion plus unila te ral lapa roscopic adrenalectomy for the treatment of patients with resistant hypertension caused by unilateral aldosterone producing adenoma [J]. Clin Hypertens, 2021, 23(5): 946- 953.
[26] Kim EY, You YK, Kim DG, et al. Is a drain necessary routinely after laparoscopic cholecystectomy for an acutely inflamed gallbladder? A retrospective analysis of 457 cases [J]. J Gastrointest Surg, 2014, 18(5): 941-946.
[27] Chai S, Pan Q, Liang C,et al. Should surgical drainage after lateral transperitoneal laparoscopic adrenalectomy be routine?- A retrospective comparative study [J]. Gland Surg 2021; 10(6): 1910-1919.
[28] Seccia TM, Camoccia B, Gomez- Sanchez EP, et al. The biology of normal zona glomerulosa and aldoseterone producing adenoma: pathological implications [J]. Endocr Rev,2018, 39(6): 1029-1056.
[29] Williams TA, Lenders JWM, Mulatero P, et al. Outcomes after adrenalectomy for unilateral primary aldosteronism:an international consensus on outcome measures and analysisof remission rates in an international cohort [J]. Lancet Diabetes Endocrinol, 2017, 5(9): 689-699.
[30] Williams TA, Gomez- Sanchez CE, Rainey WE, et al. International histopathology consensus for unilateral primary aldosteronism [J]. J Clin Endocrinol Metab, 2021, 106(1): 42-54.
[31] 中国内分泌代谢病专科联盟. 原发性醛固酮增多症诊治行业标 准[J]. 中华内分泌代谢杂志, 2022, 38(7): 555-557.
[32] Anceschi U, Mormando M, Fiori C, et al. Surgical Quality, Antihypertensive Therapy, and Electrolyte Balance: A Novel Trifecta to Assess Long- Term Outcomes of Adrenal Surgery for Unilateral Primary Aldosteronism [J]. J Clin Med, 2022, 11(3): 794.
[33] Suurd DPD, Vorselaars WMCM, Van Beek DJ, et al. Assessing Outcomes After Adrenalectomy for P rimary Aldosteronism- Early is Accurate: Retrospective Cohort Study [J]. Ann Surg, 2022, 276(5): 929-934.
[34] Peng KY, Liao HW , C han CK, e t al. P resence of subclinical hypercortisolism in clinical aldosterone- producing adenomas predicts lower clinical success [J]. Hypertension, 2020, 76(5): 1537-1544.
[35] Vilela LAP, Rassi-Cruz M, Guimaraes AG, et al. KCNJ5 somatic mutation is a predictor of hypertension remission after adrenalectomy for unilateral primary aldosteronism [J]. J Clin Endocrinol Metab, 2019, 104(10): 4695-4702
[36] Sebastian M. Factors contributing to readmissions after laparoscopic adrenalectomy [J]. Gland Surg, 2022, 11(7): 1133-1135.
[37] H ussein M , T o raih E, F ouad AM , e t al. N a tional perspective on hospital readmissions following adrenalectomy. Gland Surg, 2022; 11: 970-980.
[38] Brunt LM, Bennett HF, Teefey SA, et al. Laparoscopic ultrasound imaging of adrenal tumors during laparoscopic adrenalectomy [J]. Am J Surg, 1999, 178(6): 490-495.
[39] Kitamoto T, Kitamoto KK, Omura M, et al. Precise Mapping of Intra- Adrenal Aldosterone Activities Provides a Novel Surgical Strategy for Primary Aldosteronism [J]. J Hypertersion, 2020, 76(3): 976-984.
暂无相关信息!
暂无相关信息!
暂无相关信息!